Magnetar Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Magnetar Financial’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-44,151	Closed	-$128K	–	786
2020 Q2	$128K	Buy	+44,151	New	+$140K	﹤0.01%	411
2019 Q3	–	Sell	-325,833	Closed	-$1.02M	–	633
2019 Q2	$1.02M	Buy	325,833 +39,545	+14%	+$128K	0.02%	169
2019 Q1	$1.06M	Buy	286,288 +185,599	+184%	+$627K	0.03%	137
2018 Q4	$292K	Buy	+100,689	New	+$277K	0.01%	191
2016 Q2	–	Sell	-112,375	Closed	-$374K	–	561
2016 Q1	$374K	Sell	112,375 -2,646	-2%	-$8.25K	0.01%	259
2015 Q4	$407K	Buy	+115,021	New	+$481K	﹤0.01%	213

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Magnetar Financial's PDLI Position: Q3 2020 in Review

Magnetar Financial sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 44,151 shares — an estimated $128K sold.

Magnetar Financial first reported a position in PDLI in Q4 2015 and held it in 6 quarters. The position peaked at $1.06M in Q1 2019. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

Magnetar Financial reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
Magnetar Financial sold 44,151 PDL BioPharma, Inc. shares in Q3 2020, an estimated $128K.
Magnetar Financial first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 6 quarters.
Magnetar Financial's PDL BioPharma, Inc. position peaked at $1.06M in Q1 2019.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Magnetar Financial's 13F filing for Q3 2020, filed 16 Nov 2020.